Loading...
Mauna Kea Technologies SA
MKEAF•PNK
Healthcare
Medical - Devices
$0.37
$0.00(0.00%)

Over the last four quarters, Mauna Kea Technologies SA achieved steady financial progress, growing revenue from $1.94M in Q3 2023 to $2.13M in Q2 2024. Gross profit stayed firm with margins at 78% in Q2 2024 versus 67% in Q3 2023. Operating income totaled -$1.84M in Q2 2024, maintaining a -86% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at -$1.76M. Net income rose to -$2.34M, with EPS at -$0.05. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan